Soligenix to present at bio ceo & investor conference

Princeton, n.j. , feb. 4, 2025 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the company will deliver a corporate presentation at the bio ceo & investor conference.
SNGX Ratings Summary
SNGX Quant Ranking